Chest
Contemporary Reviews in Sleep MedicineIntermittent Hypoxemia and OSA: Implications for Comorbidities
Section snippets
Pathogenesis of IH and Its Impact at the Tissue Level
Two broad patterns of hypoxemia have been recognized.4 Patients with OSA typically manifest short intermittent high-frequency hypoxemia (cyclical pattern of oxygen desaturation lasting 15-60 s followed by reoxygenation) that occurs for 8 to 9 h during sleep and lasts for weeks to months or longer. In contrast, sustained or low-frequency hypoxemia with oxygen saturation ranging between 80% and 85% that lasts from a few minutes to hours can be seen during rapid ascent and descent from altitude
Cardiovascular Dysfunction and Disease
While it is likely that apnea-related stressors such as negative intrathoracic pressure swings, sleep fragmentation, and arousal-related sympathetic activation during sleep contribute to OSA-related cardiovascular pathophysiology, the available evidence strongly implicates repetitive hypoxemia as a major mediator of cardiac and vascular disease and dysfunction.18, 19, 20, 21, 22
IH and Metabolic Dysfunction: Mechanisms
Animal experiments in mice exposed to IH for 14 days showed marked changes in insulin resistance, impaired β-cell function, and increases in oxidative stress that improved only partially after cessation of hypoxic exposure.46 Intermittent hypoxia as compared with room air also caused dyslipidemia in mice with elevation in serum total cholesterol and triglyceride levels that correlated with the degree of hypoxemia and was more marked in lean than obese mice.7 Data also suggest differential
OSA, Glucose Intolerance, and Diabetes Risk
Cross-sectional studies in subjects with OSA have shown an association between severity of sleep apnea and glucose intolerance and the likely risk for developing diabetes.50 The Sleep Heart Health Study that followed 2,665 subjects for 5 years showed an independent association between severity of sleep apnea as determined by AHI and nocturnal hypoxemia and an increased risk of developing glucose intolerance and potentially type 2 diabetes mellitus.51 This effect was independent of BMI and waist
IH and Cognitive Impairment: Mechanisms
Adults rats exposed to IH (12 h/d up to 14 days) showed impaired cognition that persisted at 14 days of recovery. A sevenfold to eightfold greater increase in apoptosis was also noted in the CA-1 hippocampus and cortical region after 1 to 2 days of IH.61 Experiments in a rat model showed differential effects of intermittent hypoxia and OSA on the brain.62 Brain tissue oxygen levels were higher in rats subjected to obstructive apneas compared with those subjected to intermittent hypoxia, and
IH, OSA, and Cognitive Impairment
Cognitive impairment in OSA includes daytime sleepiness and other cognitive and behavioral deficits that extend well beyond daytime sleepiness. Mild cognitive impairment similar to aging is also noted in patients with severe OSA. Cognitive impairment and dementia were seen more commonly in elderly women who had OSA as compared with no OSA and correlated with the severity of sleep apnea and hypoxia.67 Mild cognitive impairment as noted in the Apnea Positive Pressure Long-term Efficacy Study
OSA, Oncogenesis, and Cancer Risk
In vitro studies have demonstrated the pro-oncogenic properties of hypoxia.74 This is mediated mainly by the enhanced posttranslational effect of HIF, which in turn results in increased expression of vascular endothelial growth factor (VEGF), formation of new capillaries, tumor growth, and metastasis.15, 16, 74 Laboratory studies have also demonstrated that low-frequency intermittent hypoxia has similar proangiogenic and tumor growth promoting effects.14, 75, 76
Based on this evidence, a
Conclusions
In summary, data from both animal and human studies suggests a dominant role for OSA-associated IH as a major contributor to multiorgan comorbidity and mortality. More studies are needed to address the interacting effects of IH and obesity, the differential effects of both short-term and long-term hypoxia, and the effect of CPAP treatment.
Acknowledgments
Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Somers has served as a consultant for ResMed; Respicardia, Inc; Sorin Group; and PricewaterhouseCoopers LLP, and as a principal investigator or co-investigator on grants from Respironics Charitable Foundation. He is also involved in intellectual property development in sleep and cardiovascular disease with Mayo Clinic Health Solutions (Mayo Foundation for Medical Education and
References (86)
- et al.
Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP
J Biol Chem
(2001) - et al.
The role of ganglionated plexi in apnea-related atrial fibrillation
J Am Coll Cardiol
(2009) - et al.
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation
J Am Coll Cardiol
(2007) - et al.
Sleep apnoea and nocturnal angina
Lancet
(1995) - et al.
Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease
Chest
(2000) - et al.
Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults
J Am Coll Cardiol
(2013) - et al.
Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome
Am J Cardiol
(2009) - et al.
Obstructive sleep apnea and pulmonary hypertension
Prog Cardiovasc Dis
(2009) - et al.
Obstructive sleep apnea and type 2 diabetes: interacting epidemics
Chest
(2008) - et al.
Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome
J Am Coll Cardiol
(2013)
Neurocognitive impairment in obstructive sleep apnea
Chest
Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea
Sleep Med
Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea
Respir Physiol Neurobiol
Spanish Sleep Network Obstructive sleep apnea is associated with cancer mortality in younger patients
Sleep Med
Increased prevalence of sleep-disordered breathing in adults
Am J Epidemiol
Pathophysiology of sleep apnea
Physiol Rev
Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study
Am J Respir Crit Care Med
Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms
J Appl Physiol (1985)
Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2
Physiol Rev
Metabolic effects of intermittent hypoxia in mice: steady versus high-frequency applied hypoxia daily during the rest period
Am J Physiol Regul Integr Comp Physiol
Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia
J Appl Physiol (1985)
14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans
Eur Respir J
Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more
Am J Respir Crit Care Med
Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link
Eur Respir J
Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome
Am J Respir Crit Care Med
Mechanisms of vascular damage in obstructive sleep apnea
Nat Rev Cardiol
Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism
Hypertension
The role of hypoxia-inducible factors in tumorigenesis
Cell Death Differ
Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination
Int J Cancer
Alveolar hypoxia promotes murine lung tumor growth through a VEGFR-2/EGFR-dependent mechanism
Cancer Prev Res (Phila)
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Nat Rev Drug Discov
Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans
J Appl Physiol (1985)
Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans
J Appl Physiol (1985)
Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea
Circulation
Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects
Hypertension
Sympathetic neural mechanisms in obstructive sleep apnea
J Clin Invest
Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea
Circulation
An analysis of the primary cardiovascular reflex effects of stimulation of the carotid body chemoreceptors in the dog
J Physiol
Role of carotid-body chemoreceptors and their reflex interactions in bradycardia and cardiac arrest
Lancet
Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension
Clin Auton Res
Elevated C-reactive protein in patients with obstructive sleep apnea
Circulation
Biology of peripheral blood cells in obstructive sleep apnea—the tip of the iceberg
Arch Physiol Biochem
Role of endothelin in intermittent hypoxia-induced hypertension
Hypertension
Cited by (429)
Multimodal Prognostic Model for Predicting Chronic Coronary Artery Disease in Patients Without Obstructive Sleep Apnea Syndrome
2024, Archives of Medical ResearchClinical and radiographic periodontal status in hypertensive patients with or without obstructive sleep apnea 10 years after diagnosis and CPAP initiation
2024, Clinical and Experimental Dental Research
Parts of this article were presented as a Sleep Network Highlight session at CHEST 2013, October 26-31, 2013, Chicago, IL.
FUNDING/SUPPORT: Dr Nieto's contributions were supported in part by the National Institutes of Health (NIH) [Grant R01HL062252-11] and by the University of Wisconsin Helfaer Endowed Chair of Public Health. Dr Somers' contribution to this work was supported by the NIH [Grant HL-65176].
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.